Developer docs
API playgroundTry for free, no card

Search company profiles

Stem Cell Network (SCN)

Full company profile

uuid0002p8w

Namestring
Stem Cell Network (SCN)
Legal namestring
Stem Cell Network
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning. In just over 16 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace.

Short descriptiontext

SCN supports cutting-edge projects that translate Canadian stem cell research discoveries into new and better treatments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell research funding, regenerative medicine research, biomedical research training, clinical trial support, biotech incubation funding
Industry4 codes
PRIMARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYBPAGADAG
STEM, Digital Literacy & Maker Education Nonprofits
Business & Public Services/Nonprofit, NGO & Social Services/Education & Youth Development Nonprofits
SECONDARYEDAAAFAL
STEM & Maker Education (Makerspaces, Coding Clubs, Robotics)
Education/Adult & Continuing Education/Community & Public Education Programs (Libraries, Community Centers)
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Health Services8000
  • Services-Educational Services8200
Product category
Regenerative Medicine Research Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Government of Canada Funding
TypeSubscription Recurring
Description

The Stem Cell Network receives government funding to support its mission of advancing stem cell and regenerative medicine research in Canada. The Government of Canada invested $45 million for the 2022-2025 period, demonstrating ongoing commitment to the network's activities.

breakthrought1d.org
2Partnership Funding
TypeSubscription Recurring
Description

SCN leverages partnership funding from organizations like Breakthrough T1D to co-fund research projects, expanding the total investment in Canadian regenerative medicine research.

stemcellnetwork.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Stem Cell Network is a Canadian national not-for-profit organization that supports cutting-edge projects translating stem cell research discoveries into new treatments. It does this by operating competitive research funding programs for translational regenerative medicine, training programs for highly qualified personnel, the annual Till & McCulloch Meetings conference, and outreach initiatives such as StemCellTalks. Recipients—academic researchers, trainees, and Canadian biotech companies—receive funding, training, and convening services at no cost, funded primarily through Government of Canada grants and partnership co-funding.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • More than 25 clinical trials supported
+2 more records
Product overview1 text field

The Stem Cell Network (SCN) is a Canadian national not-for-profit organization that functions as a multi-faceted platform supporting stem cell and regenerative medicine research. Rather than a single unified product, SCN offers an integrated ecosystem comprising: research funding programs supporting translational regenerative medicine across the research continuum; training programs including the Foundations Course, Fellowships, Internships & Exchanges, and Summer Studentships; the Till & McCulloch Meetings (TMM) as Canada's premier stem cell and regenerative medicine conference; the StemCellTalks outreach initiative for high school students; the SCN-RDMM Catalyst Grant for rare disease research; the Incubation Investment Award for biotech companies; and a Funded Research Database. Together, these offerings span the full pipeline from discovery research through clinical translation to commercialization and public engagement.

Product and service9 records
1Research Funding Programs
2Incubation Investment Award
3SCN-RDMM Catalyst Grant
Description

Catalyst grant program connecting researchers and clinicians to advance rare disease discovery and mechanistic research through the Rare Diseases: Models & Mechanisms (RDMM) network.

4Fellowships, Internships & Exchanges
Description

Training program offering fellowships, internships, and research exchanges that help graduate students, postdoctoral fellows, and other trainees gain skills for careers in regenerative medicine.

5Foundations Course
Description

Foundational training course building essential skills for success in regenerative medicine research, aimed at new trainees entering the field.

6Summer Studentships
Description

Summer research studentships providing paid research opportunities for undergraduate students exploring careers in regenerative medicine.

7Till & McCulloch Meetings (TMM)
Description

Annual conference that is Canada's premier stem cell and regenerative medicine meeting, bringing together scientists, students, industry experts, and policy scholars for plenaries, breakouts, networking, and the Cells I See art contest.

8Funded Research Database
Description

Public, searchable database of all SCN-funded research projects and clinical trials since 2016, supporting transparency and researcher discovery.

9StemCellTalks
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Breakthrough T1D (formerly JDRF)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Partnership to fund four Canadian research projects focused on cell replacement therapies for type 1 diabetes, running from May 2025 to April 2027. The partnership is part of SCN's broader $33 million investment supporting 36 regenerative medicine research projects and clinical trials. Projects include preclinical development of a manufactured islet replacement product by Vancouver-based Lunar Therapeutics, and research on islet cryopreservation, encapsulation devices, and human immune system models.

breakthrought1d.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stem Cell Network (SCN)

Regenerative Medicine Research Fundingstemcellnetwork.ca

SCN supports cutting-edge projects that translate Canadian stem cell research discoveries into new and better treatments.

What Stem Cell Network (SCN) does

Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning. In just over 16 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace.

Stem Cell Network (SCN) firmographics

Firmographics
Name
Stem Cell Network (SCN)
Legal name
Stem Cell Network
Website
https://stemcellnetwork.ca
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
SCN supports cutting-edge projects that translate Canadian stem cell research discoveries into new and better treatments.
Ownership category
akta.pro rank

Stem Cell Network (SCN) industry classification

Industry
Product category
Regenerative Medicine Research Funding
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Health Services (8000), Services-Educational Services (8200)
akta.pro industry
PRIMARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYBPAGADAG
STEM, Digital Literacy & Maker Education Nonprofits
Business & Public Services/Nonprofit, NGO & Social Services/Education & Youth Development Nonprofits
SECONDARYEDAAAFAL
STEM & Maker Education (Makerspaces, Coding Clubs, Robotics)
Education/Adult & Continuing Education/Community & Public Education Programs (Libraries, Community Centers)

Keywords

  • Stem cell research funding
  • Regenerative medicine research
  • Biomedical research training
  • Clinical trial support
  • Biotech incubation funding

Where Stem Cell Network (SCN) is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Stem Cell Network (SCN) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Government of Canada Funding: The Stem Cell Network receives government funding to support its mission of advancing stem cell and regenerative medicine research in Canada. The Government of Canada invested $45 million for the 2022-2025 period, demonstrating ongoing commitment to the network's activities.
  2. Partnership Funding: SCN leverages partnership funding from organizations like Breakthrough T1D to co-fund research projects, expanding the total investment in Canadian regenerative medicine research.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Stem Cell Network (SCN) product offering

Product offering

Core offering

Stem Cell Network is a Canadian national not-for-profit organization that supports cutting-edge projects translating stem cell research discoveries into new treatments. It does this by operating competitive research funding programs for translational regenerative medicine, training programs for highly qualified personnel, the annual Till & McCulloch Meetings conference, and outreach initiatives such as StemCellTalks. Recipients—academic researchers, trainees, and Canadian biotech companies—receive funding, training, and convening services at no cost, funded primarily through Government of Canada grants and partnership co-funding.

Product overview

The Stem Cell Network (SCN) is a Canadian national not-for-profit organization that functions as a multi-faceted platform supporting stem cell and regenerative medicine research. Rather than a single unified product, SCN offers an integrated ecosystem comprising: research funding programs supporting translational regenerative medicine across the research continuum; training programs including the Foundations Course, Fellowships, Internships & Exchanges, and Summer Studentships; the Till & McCulloch Meetings (TMM) as Canada's premier stem cell and regenerative medicine conference; the StemCellTalks outreach initiative for high school students; the SCN-RDMM Catalyst Grant for rare disease research; the Incubation Investment Award for biotech companies; and a Funded Research Database. Together, these offerings span the full pipeline from discovery research through clinical translation to commercialization and public engagement.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Funding Programs
  • Incubation Investment Award
  • SCN-RDMM Catalyst Grant Catalyst grant program connecting researchers and clinicians to advance rare disease discovery and mechanistic research through the Rare Diseases: Models & Mechanisms (RDMM) network.
  • Fellowships, Internships & Exchanges Training program offering fellowships, internships, and research exchanges that help graduate students, postdoctoral fellows, and other trainees gain skills for careers in regenerative medicine.
  • Foundations Course Foundational training course building essential skills for success in regenerative medicine research, aimed at new trainees entering the field.
  • Summer Studentships Summer research studentships providing paid research opportunities for undergraduate students exploring careers in regenerative medicine.
  • Till & McCulloch Meetings (TMM) Annual conference that is Canada's premier stem cell and regenerative medicine meeting, bringing together scientists, students, industry experts, and policy scholars for plenaries, breakouts, networking, and the Cells I See art contest.
  • Funded Research Database Public, searchable database of all SCN-funded research projects and clinical trials since 2016, supporting transparency and researcher discovery.
  • StemCellTalks

Quantifiable outcome

  • More than 25 clinical trials supported
  • +2 more outcomes

Companies that use Stem Cell Network (SCN)

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Stem Cell Network (SCN) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Stem Cell Network (SCN) partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Breakthrough T1D (formerly JDRF)coreStrategic or Co-development Partner · 1 May 2025Partnership to fund four Canadian research projects focused on cell replacement therapies for type 1 diabetes, running from May 2025 to April 2027. The partnership is part of SCN's broader $33 million investment supporting 36 regenerative medicine research projects and clinical trials. Projects include preclinical development of a manufactured islet replacement product by Vancouver-based Lunar Therapeutics, and research on islet cryopreservation, encapsulation devices, and human immune system models.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Stem Cell Network (SCN) competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Stem Cell Network (SCN) social profiles

Digital presence

Stem Cell Network (SCN) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stem Cell Network (SCN) leadership team

Management profile

Number of profiles

Profiles6 records

Stem Cell Network (SCN) funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stem Cell Network (SCN) M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stem Cell Network (SCN)

What does Stem Cell Network (SCN) do?

Stem Cell Network is a Canadian national not-for-profit organization that supports cutting-edge projects translating stem cell research discoveries into new treatments. It does this by operating competitive research funding programs for translational regenerative medicine, training programs for highly qualified personnel, the annual Till & McCulloch Meetings conference, and outreach initiatives such as StemCellTalks. Recipients—academic researchers, trainees, and Canadian biotech companies—receive funding, training, and convening services at no cost, funded primarily through Government of Canada grants and partnership co-funding.

Is Stem Cell Network (SCN) a public or private company?

Stem Cell Network (SCN) is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Stem Cell Network (SCN) founded?

Stem Cell Network (SCN) was founded in 2001. It employs 11 to 50 people.

Where is Stem Cell Network (SCN) based?

Stem Cell Network (SCN) is headquartered in Ottawa, Canada, in the North America region.

How does Stem Cell Network (SCN) make money?

Two revenue lines are on record. Government of Canada Funding is the primary driver. The others are partnership Funding.

Does Stem Cell Network (SCN) have an API?

No public API is recorded for Stem Cell Network (SCN).

What industry is Stem Cell Network (SCN) in?

Stem Cell Network (SCN)'s product category is Regenerative Medicine Research Funding. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAAAGAA, Stem Cell–Based Regenerative Therapies. Its NAICS code is 541714 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Global NewsUSask professor recognized for pediatric stem cell researchDr. Tyler Wenzel, a USask professor, was named a Rising Star Awardee by Canada's Stem Cell Network for his work in regenerative medicine. He is developing a stem cell transplant cure for X-linked Adrenoleukodystrophy, a rare pediatric brain disease, with preliminary data showing disease markers disappear. If successful, treatment could begin in Saskatchewan within a decade.UtorontoU of T Engineering researchers and startup boutIQ solutions partner to advance heart repair therapiesUniversity of Toronto professors and the startup boutIQ solutions Inc. have secured a $421,000 research grant from the Stem Cell Network to advance stem cell-derived therapies for heart repair. The initiative involves applying boutIQ's proprietary AI-powered platform to optimize cell culture media in collaboration with the Acceleration Consortium and University Health Network. This partnership aims to enhance the maturation and function of therapeutic cells to improve their integration into damaged heart tissue.Breakthrought1DStem Cell Network partnership for cell therapy research in CanadaBreakthrough T1D (formerly JDRF) and the Stem Cell Network (SCN) have partnered to fund four new Canadian research projects focused on cell replacement therapies for type 1 diabetes, running from May 2025 to April 2027. The projects include a preclinical development of a manufactured islet replacement product by Vancouver-based Lunar Therapeutics, and three additional research initiatives targeting islet cryopreservation, encapsulation devices, and human immune system models. The partnership is part of SCN's broader $33 million investment supporting 36 regenerative medicine research projects and clinical trials.NewswireGovernment of Canada invests in cutting-edge research and the next generation of scientistsThe Government of Canada announced an investment of up to $171.6 million in five science and research organizations through the Strategic Science Fund. The funding, awarded via a competitive process, supports entities including Actua, ArcticNet Inc., BioCanRx, CASC, and the Stem Cell Network for projects ranging from health solutions to climate change research.GlobeNewswireStem Cell Network Warns that Claims of Stem Cell Treatments for COVID-19 Are Unfounded and MisleadingThe Stem Cell Network warns that no stem cell-based treatment for COVID-19 is clinically tested or government-approved, urging caution against unproven therapies. It advises consulting doctors and following public health guidance, noting legitimate treatments will be announced through recognized medical authorities.GlobeNewswireCanada’s Stem Cell Network Welcomes Renewed Federal Commitment for Stem Cell & Regenerative Medicine ResearchThe Canadian government announced an $18 million multi-year investment in the Stem Cell Network through Budget 2019. The network has invested $100 million since 2001 and catalyzed 18 clinical trials and 17 startups. It expects new therapies to move forward.